Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SH3 domain and tetratricopeptide repeats-containing protein 2 (SH3TC2) is a protein expressed mainly in Schwann cells of the peripheral nervous system, where it plays a significant role in myelination and the maintenance of the node of Ranvier. The protein contains two N-terminal Src homology 3 (SH3) domains and multiple tetratricopeptide repeat (TPR) domains, suggesting a role as a scaffold or adapter protein in cellular trafficking processes. SH3TC2 localizes to the plasma membrane and the perinuclear endocytic recycling compartment, interacting with proteins such as Rab11, which is involved in membrane protein recycling. Mutations in the SH3TC2 gene are causally linked to Charcot-Marie-Tooth disease type 4C (CMT4C), an autosomal recessive demyelinating neuropathy characterized by hypomyelination, motor and sensory neuron dysfunction, and abnormal nodal architecture in peripheral nerves. There are no reported drugs targeting the protein, nor established mechanisms of drug action on SH3TC2, but genetic and pathological markers are important for diagnosis and research into demyelinating neuropathies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH3 domain and tetratricopeptide repeats-containing protein 2 (SH3TC2).